Hong Kong’s stock exchange operator is modifying its listing rules to make it easier for specialist technology companies and special-purpose acquisition companies (SPACs) to raise funds from investors, after a …
Initial public offering (IPO) activity in Hong Kong is gearing up for a busier second half of the year, shaking off a slow first six months as more Chinese companies …
QuantumPharm’s shares soared on their trading debut in Hong Kong, as traders piled into the stock even before the AI-powered pharmaceuticals researcher posted any profit. Listed under the stock code …
The IPO of Quantum Pharm, known also as XtalPi, has been portrayed as a showcase of Hong Kong’s major role in supporting China’s “hard technology” drive. Hong Kong finance chief …
“Today, we have a perfect example and story of a company born and raised in Hong Kong, which expanded into the Greater Bay Area and now has a very successful …
Tencent-backed QuantumPharm, an artificial intelligence (AI) drug researcher, has become Hong Kong’s third-largest listing of the year after pricing its initial public offering (IPO) at the low end of the …
QuantumPharm received about HK$4.3 billion of orders based on 12 major brokers’ margin lending to clients for the retail tranche of its IPO when the books closed at noon on …
Bright Smart Securities, the biggest local broker to offer margin financing for IPOs, also received a good response but did not disclose the number. It is the first IPO under …
Tencent-backed artificial intelligence (AI) drug researcher QuantumPharm is raising up to HK$1.13 billion (US$144.5 million) in a Hong Kong initial public offering (IPO) from Tuesday, eyeing the first listing under …